Effect of GLP-1 agonists on weight loss in patients with polycystic ovary syndrome and obesity: A single-center study

BACKGROUND: Weight loss of >5% in patients with polycystic ovary syndrome and obesity (PCOS–O) is believed to improve underlying drivers of the syndrome. Weight loss facilitated by GLP-1 agonists in patients with PCOS–O is not well characterized. In this single-center retrospective study, we dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Srinivasan, Dushyanth, Lofton, Holly F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661916/
https://www.ncbi.nlm.nih.gov/pubmed/37990710
http://dx.doi.org/10.1016/j.obpill.2022.100016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661916/
https://www.ncbi.nlm.nih.gov/pubmed/37990710
http://dx.doi.org/10.1016/j.obpill.2022.100016

Ejemplares similares